J Hamada Selected Research

J Hamada Research Topics

Disease

7	Neoplasms (Cancer) 07/2013 - 01/2000
4	Ischemia 01/2003 - 09/2001
3	Neoplasm Metastasis (Metastasis) 07/2013 - 01/2000
2	Brain Ischemia (Cerebral Ischemia) 01/2003 - 01/2003
2	Aneurysm (Aneurysms) 12/2001 - 06/2000
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2003
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 11/2001
1	Hypoxia (Hypoxemia) 10/2001
1	Inborn Genetic Diseases (Disease, Hereditary) 10/2001
1	Hypotension (Low Blood Pressure) 09/2001
1	Colonic Neoplasms (Colon Cancer) 04/2001
1	Autoimmune enteropathy 04/2001
1	Periarthritis 04/2001
1	Hemorrhage 03/2001
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2001
1	Retinal Perforations 01/2001
1	Carcinoma (Carcinomatosis) 09/2000
1	Ruptured Aneurysm 09/2000
1	Squamous Cell Carcinoma of Head and Neck 09/2000
1	Intracranial Vasospasm 09/2000
1	Carcinogenesis 06/2000
1	Hepatitis 02/2000
1	Hepatocellular Carcinoma (Hepatoma) 02/2000
1	Breast Neoplasms (Breast Cancer) 01/2000

Drug/Important Bio-Agent (IBA)

3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2003 - 01/2001
2	Proteins (Proteins, Gene)FDA Link 01/2003 - 04/2001
2	Neuroprotective AgentsIBA 01/2003 - 11/2001
2	DNA (Deoxyribonucleic Acid)IBA 02/2001 - 01/2000
1	MicroRNAs (MicroRNA)IBA 07/2013
1	IndazolesIBA 01/2003
1	Caspase 12IBA 01/2003
1	Peroxynitrous Acid (Peroxynitrite)IBA 01/2003
1	3- (2- (4- (3- chloro- 2- methylphenyl)1- piperazinyl)ethyl)5,6- dimethoxy- 1- (4- imidazolylmethyl)- 1H- indazol dihydrochloride 3.5 hydrateIBA 01/2003
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2003
1	salicylhydroxamic acid (SHAM)IBA 01/2003
1	Vanadates (Orthovanadate)IBA 11/2001
1	SodiumIBA 11/2001
1	Insulin-Like Growth Factor I (IGF-1)IBA 11/2001
1	Transcription Factors (Transcription Factor)IBA 10/2001
1	Oxygen (Dioxygen)IBA 10/2001
1	Codon (Codons)IBA 10/2001
1	NitritesIBA 09/2001
1	AutoantigensIBA 04/2001
1	AntigensIBA 04/2001
1	tricalcium phosphateIBA 04/2001
1	Durapatite (Hydroxylapatite)IBA 04/2001
1	Phosphates (Orthophosphate)IBA 04/2001
1	CalciumIBA 04/2001
1	Oxidized CelluloseIBA 03/2001
1	Epidermal Growth Factor (EGF)IBA 02/2001
1	PeroxidesIBA 02/2001
1	8-Hydroxy-2'-DeoxyguanosineIBA 02/2001
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2001
1	Endothelin-1 (Endothelin 1)IBA 01/2001
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 09/2000
1	matrigelIBA 09/2000
1	diisopropyl 1,3-dithiol-2-ylidenemalonate (malotilate)IBA 09/2000
1	Hematoxylin (Haematoxylon)IBA 06/2000
1	Eosine Yellowish-(YS) (Eosin)IBA 06/2000
1	trichrome stainIBA 06/2000
1	Biological ProductsIBA 06/2000
1	CopperIBA 02/2000
1	EnzymesIBA 01/2000
1	Estrogen ReceptorsIBA 01/2000
1	Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA 01/2000
1	Annexin A2 (Annexin II)IBA 01/2000
1	OsteopontinIBA 01/2000
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2000

Therapy/Procedure

1	Ligation 12/2001
1	Length of Stay 11/2001
1	Drug Therapy (Chemotherapy) 01/2000